Trials / Completed
CompletedNCT05824858
A Study of the Effect of Food on LY3537982 in Healthy Participants
A Phase 1 Study to Evaluate the Effect of Food on the LY3537982 Pharmacokinetics in Health Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to conduct blood tests to measure how much LY3537982 is in the bloodstream and how the body handles and eliminates LY3537982 after meals and on an empty stomach. The study will also evaluate the safety and tolerability of LY3537982. Participants will stay in the research center during the study, which will last about one week, not including screening.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY3537982 | Administered orally. |
Timeline
- Start date
- 2023-04-12
- Primary completion
- 2023-06-17
- Completion
- 2023-06-17
- First posted
- 2023-04-24
- Last updated
- 2023-09-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05824858. Inclusion in this directory is not an endorsement.